Skip to content

Dr Robert Foale

Robert Foale
  • Location: Suffolk
  • Year of Fellowship: 2019
  • Route to Fellowship: Meritorious Contributions to Clinical practice

Field of work

Clinical practice (private)

Areas of special interest

  • Gene therapy for canine diabetes mellitus
  • Small animal medicine
  • Small animal medical oncology

Areas of support

  • Collaborative research
  • Promoting knowledge and best practice

Professional positions

  • Clinical Director, Director and Partner, Dick White Referrals
  • Honorary Associate Professor of Small Animal Medicine, University of Nottingham
  • ECVIM-CA Residency Programme Director, Dick White Referrals
  • ECVIM-CA Examination Committee member
  • Governor, The Stephen Perse Foundation, Cambridge


Rob qualified from the RVC in 1996, having previously completed a joint honours degree in Physiology and Pharmacology at King's College, London.

He spent four years in mixed practice in Hertfordshire and Sterlingshire before joining the medicine service at the Queen's Veterinary School Hospital as a ECVIM-CA Resident in small animal medicine, where he remained until the end of 2003.

He then joined Dick White Referrals in 2004, founding the internal medicine and medical oncology services and served as Head of the Medicine Service from 2004 to 2016, before taking on his current roles of Clinical Director, Director and Partner.

He obtained his CertSAM in 2001, his DSAM in 2003, his DipECVIM-CA in 2005 and became a Fellow of the RCVS in 2019.

He was also a special lecturer at the University of Nottingham from 2007-2010 before becoming an Honorary Associate Professor of Small Animal Medicine at this institution. Teaching and inspiring students has always been a passion for Rob and he taught the undergraduate small animal endocrinology course from 2007 - 2016.

He is also the ECVIM-CA Residency Programme Director at DWR and sits on the ECVIM-CA examination committee.

His main clinical interests are endocrinology, haematology and medical oncology. His active research interest is in the development of a gene therapy treatment for insulin-deficient diabetic dogs, which is now in clinical trial and has so far led to four abstracts and two papers being published.

Back to results